42Stockpicking

PCVX

Vaxcyte Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
2,3
33rd %ile · 404p
P/Si
EV/Salesi
Div yieldi

Kursudvikling

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026basic
Prishistorik
6 år
Pris-dage
1504
Årsregnskaber
9
Peers
0/0
Valuation
1/6
Fundamentals
5/8
Datovindue
2020-06-12 til 2026-06-08

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 4,0 års prishistorik før ideal/full.
  • Kør compute-multiples for manglende valuation metrics.
  • Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.

Seneste assessment

PCVX vurderet 2026-06-10

Score
39.8%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

40%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

46%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

16%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

74%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

29%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

45%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
-12.174
Net 90d (værdi)
-638.103 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
18.6.2026PICKERING GRANTCHIEF EXECUTIVE OFFICER▼ SALG-225-11.815 USDsec
18.6.2026GUGGENHIME ANDREWPRESIDENT AND CFO◆ OPT.10.00053.500 USDsec
18.6.2026GUGGENHIME ANDREWPRESIDENT AND CFO▼ SALG-10.000-530.000 USDsec
18.6.2026PICKERING GRANTCHIEF EXECUTIVE OFFICER◆ OPT.225403 USDsec
15.6.2026Gilbert Halley E· ANDET2.265sec
15.6.2026Paya Carlos V· ANDET2.265sec
15.6.2026Loxam Teri· ANDET2.265sec
15.6.2026Lee Jacks· ANDET2.265sec
15.6.2026Furey John· ANDET2.265sec
15.6.2026Drapeau Anne S· ANDET2.265sec
15.6.2026BRANDICOURT OLIVIER· ANDET2.194sec
15.6.2026Lukatch Heath· ANDET2.265sec
1.6.2026Wassil JimCHIEF OPERATING OFFICER▼ SALG-1.949-96.288 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-2,30-1,77-29.6%-29.6%Miss
2025Q430.1.2026-1,80-1,50-19.7%-19.7%Miss
2025Q330.10.2025-1,56-1,24-26.3%-26.3%Miss
2025Q230.7.2025-1,22-1,16-5.0%-5.0%Inline